A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet. 2013 Jul; 45(7):747-55.